APA (7th ed.) Citation

Yurista, S. R., Silljé, H. H. W., Rienstra, M., de Boer, R. A., & Westenbrink, B. D. (2020). Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? Cardiovascular Diabetology, 19(1), 1. https://doi.org/10.1186/s12933-019-0984-0

Chicago Style (17th ed.) Citation

Yurista, Salva R., Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, and B. Daan Westenbrink. "Sodium-glucose Co-transporter 2 Inhibition as a Mitochondrial Therapy for Atrial Fibrillation in Patients with Diabetes?" Cardiovascular Diabetology 19, no. 1 (2020): 1. https://doi.org/10.1186/s12933-019-0984-0.

MLA (9th ed.) Citation

Yurista, Salva R., et al. "Sodium-glucose Co-transporter 2 Inhibition as a Mitochondrial Therapy for Atrial Fibrillation in Patients with Diabetes?" Cardiovascular Diabetology, vol. 19, no. 1, 2020, p. 1, https://doi.org/10.1186/s12933-019-0984-0.